CAS RN: 253195-80-1
8-bromo-2,3-dihydro-1H-indolizin-5-one
Product Availability
Choose a grade to view its available package options.
1 package records 0 with current stock 1 grade group
Grade
97% (1)
In stock only
Batch No. Package Availability Lead Time Inquiry
Batchno.20250917
100mg / 250mg / 500mg
Out of stock
8-10 business days Inquiry
GET A QUOTE
This product has historical factory records. Recorded pack sizes and purity can be used as a supply reference, while project-specific availability is confirmed by inquiry.
Pack sizes on record: 0.25g
Available purity: ≥95%
Inventory rows with stock: 0
Bulk packaging: confirmed by inquiry
Request Bulk Quote
Recorded sizes, purity and stock details for CAS 253195-80-1
Pack Size
Recorded Purity
Available Qty
Ship From
Inquiry
0.25g
≥95%
0
Out of Stock
Shenzhen
Inquiry
253195-80-1 / 8-bromo-2,3-dihydro-1H-indolizin-5-one
Standard CAS: 253195-80-1
Multi CAS: No
Basic Information
copy
CAS
253195-80-1 copy
Multi CAS
No copy
Molecular Formula
C8H8BrNO copy
Molecular Weight
214.060000 copy
Exact Mass
212.978930 copy
SMILES
C1CC2=C(C=CC(=O)N2C1)Br copy
InChI
InChI=1S/C8H8BrNO/c9-6-3-4-8(11)10-5-1-2-7(6)10/h3-4H,1-2,5H2 copy
InChIKey
OGDBKUKFROETQZ-UHFFFAOYSA-N copy
Computed Properties
copy
Structural Parameters
Heavy atom count
11 copy
Aromatic heavy atom count
6 copy
Fraction Csp3
0.38 copy
H-bond acceptors
2 copy
Molar refractivity
46.72 copy
TPSA
22 copy
LogP / Solubility
WLOGP
1.56 copy
MLOGP
1.37 copy
XLogP3
1.2 copy
Consensus LogP
1.38 copy
Log S (ESOL)
-2.55 copy
Class (ESOL)
Moderately soluble copy
Log S (Ali)
-2.44 copy
Class (Ali)
Moderately soluble copy
Log S (SILICOS-IT)
-2.34 copy
Class (SILICOS-IT)
Moderately soluble copy
ADME
GI absorption
High copy
BBB permeant
Yes copy
P-gp substrate
No copy
CYP1A2 inhibitor
No copy
CYP2C19 inhibitor
No copy
CYP2C9 inhibitor
No copy
CYP2D6 inhibitor
No copy
CYP3A4 inhibitor
No copy
Log Kp (skin permeation)
-2.92 copy
Drug-likeness / Medicinal Chemistry
Lipinski
Yes copy
Ghose
No copy
Veber
Yes copy
Egan
Yes copy
Muegge
Yes copy
Bioavailability score
0.55 copy
Leadlikeness
No copy
Synthetic Accessibility
1.5 copy